Evidence map›Paper›PMID 41318218›Full record

ReviewCancer reports (Hoboken, N.J.)2025

Hepatocellular Carcinoma With Small Bowel Metastasis and Intussusception: A Case Report and Literature Review.

Meng-Kai Hsu, Po-Da Chen, Yao-Ming Wu

Abstract readCase ReportsReview
In one paragraph

Review in Cancer reports (Hoboken, N.J.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Meng-Kai HsuDepartment of Surgery, National Taiwan University Hospital, Taipei, Taiwan.ORCID 0000-0001-9643-6906
Po-Da ChenDepartment of Surgery, National Taiwan University Hospital, Taipei, Taiwan.ORCID 0000-0003-2110-7694
Yao-Ming WuDepartment of Surgery, National Taiwan University Hospital, Taipei, Taiwan.ORCID 0000-0002-1720-7863

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundHepatocellular carcinoma (HCC) is a common primary liver malignancy. Despite advancements in treatment, HCC often has a poor prognosis because of frequent recurrence and metastasis. Hematogenous metastasis to the gastrointestinal tract is uncommon, and metastasis to the small intestine is particularly rare. CASE: We report a case of a 72-year-old man with a history of hepatitis C virus and alcohol-related HCC. In 2017, he was initially managed with atypical hepatectomy of segments 5 and 6. He later developed bone and lung metastases, controlled by sequential systemic therapies. In early 2024, after undergoing a craniotomy for hemorrhagic occipital brain metastasis, he presented with diffuse abdominal pain, fullness, and vomiting. Imaging revealed distal ileal intussusception. A segmental small bowel resection was performed, and a fungating ileal tumor was identified as the lead point. Histology confirmed metastatic HCC (i.e., Hepar-1 positive). The postoperative course was uneventful, but within 3 months, new metastatic lesions appeared in the stomach and left breast; the latter was treated with a partial mastectomy.

conclusionSmall intestine metastasis from HCC, although rare, should be considered in patients with gastrointestinal symptoms or unexplained elevated tumor markers. Surgical resection is the most effective treatment approach, with minimally invasive and endoscopic techniques available for select cases.

Indexed as

Carcinoma, HepatocellularIleal NeoplasmsIntussusceptionLiver NeoplasmsAgedHepatectomyHumansIntestine, SmallMalebowel obstructiongastrointestinal tract metastasishepatocellular carcinomaintussusceptionsmall bowel metastasissurgical resection

Identifiers

PMID41318218
PMCPMC12664738

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.